Leveraging Engineered Gamma-Delta T Cells for Enhanced Tumor Cell Destruction in GBM
Time: 2:00 pm
day: Conference Day 2
Details:
- Overcoming challenges of antigen selection with engineered T-cells for GBM tumor destruction
- Using gamma-delta T cells to combine an innate and adaptive immune response in GBM
- Determining the best combinatorial approach for cell therapy in solid tumors
